FutureMed is a one-of-a-kind multidisciplinary program tailored for Physicians, Healthcare Innovators, MedTech Executives, BioTech Executives, Entrepreneurs, Investors and those with an interest in the future of healthcare.
Physicians: Intended for physicians across the medical spectrum, from full time clinicians to academicians. Any clinician who is looking to understand the global trends, disruptive technologies in medicine and healthcare should fully participate in this program. FutureMed participants will network with the top innovators who are leading the technology revolution. You will learn about emerging tools to improve your clinical practice, research and your ability to identify and address pain points in your clinical practice.
Inventors & Innovators: Anyone who is involved and interested in innovation to develop novel solutions (and improve current approaches) to address unmet needs across the healthcare ecosystem: ranging from medical devices, software and mobile Apps, new drugs and therapeutic approaches, to the utilization of big data, artificial intelligence, electronic medical records and more….
MedTech & BioTech Executives & Investors: Technological breakthroughs are emerging from the intersection of various exponentially growing fields: Where 3D printing and Stem Cell biology meet, we see a new organ regeneration industry emerge; where cloud computing, microfluidics and artificial intelligence intersect we witness the creation of the Star Trek medical Tricorder. Any medical CEO, CTO or CMO who is not thrilled and terrified by the rapid explosion of technology doesn’t understand the pace and impact of this change.
This program will enable participating executives to get an inspired vision of the future, forming an understanding of what is in the lab today and what is likely to come into the clinic and practice in the years ahead. Opportunities in fields like diagnostic technologies, genomic and stem cell therapies, bioinformatics, electronic health records, nanomaterial enabled technologies, personalized pharmaceuticals and robotics, just to name a few, will be reviewed and discussed.